Avestar Capital, LLC Nektar Therapeutics Transaction History

Avestar Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$16.91 - $36.27 $338 - $725	-20 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$31.0 - $36.3 $372 - $435	12 Added 150.0%	20 $0
Q4 2018 Jan 25, 2019	BUY	$30.43 - $56.65 $243 - $453	8 New	8 $0
Q3 2018 Oct 23, 2018	SELL	$46.46 - $68.49 $650 - $958	-14 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$46.25 - $104.45 $647 - $1,462	14 New	14 $0

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.